BR0015478A - Métodos de diminuição do volume de uma célula, de tratamento de pessoa e de inflamação, de dessensibilização de dente e de redução de dor em úlceras, composição terapêutica, cimento dentário, goma de mascar ou bala e composições dentárias e de branquamento dentário - Google Patents

Métodos de diminuição do volume de uma célula, de tratamento de pessoa e de inflamação, de dessensibilização de dente e de redução de dor em úlceras, composição terapêutica, cimento dentário, goma de mascar ou bala e composições dentárias e de branquamento dentário

Info

Publication number
BR0015478A
BR0015478A BR0015478-4A BR0015478A BR0015478A BR 0015478 A BR0015478 A BR 0015478A BR 0015478 A BR0015478 A BR 0015478A BR 0015478 A BR0015478 A BR 0015478A
Authority
BR
Brazil
Prior art keywords
dental
tooth
therapeutic composition
methods
cell volume
Prior art date
Application number
BR0015478-4A
Other languages
English (en)
Inventor
Milton Hodosh
Original Assignee
Milton Hodosh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/439,858 external-priority patent/US6099868A/en
Application filed by Milton Hodosh filed Critical Milton Hodosh
Publication of BR0015478A publication Critical patent/BR0015478A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dental Preparations (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

"MéTODOS DE DIMINUIçãO DO VOLUME DE UMA CéLULA, DE TRATAMENTO DE PESSOA E DE INFLAMAçãO, DE DESSENSIBILIZAçãO DE DENTE E DE REDUçãO DE DOR EM úLCERAS, COMPOSIçãO TERAPêUTICA, CIMENTO DENTáRIO, GOMA DE MASCAR OU BALA E COMPOSIçõES DENTáRIAS E DE BRANQUEAMENTO DENTáRIO". Proporcionam-se composição terapêutica e método de uso da composições. A composição inclui um agente osmótico e um agente ativo. O agente osmótico melhora o suprimento do agente ativo ao local tecidular visado.
BR0015478-4A 1999-11-12 2000-11-13 Métodos de diminuição do volume de uma célula, de tratamento de pessoa e de inflamação, de dessensibilização de dente e de redução de dor em úlceras, composição terapêutica, cimento dentário, goma de mascar ou bala e composições dentárias e de branquamento dentário BR0015478A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/439,858 US6099868A (en) 1999-11-12 1999-11-12 Method of using potassium nitrate for pain reduction
US09/633,424 US6524623B1 (en) 1999-11-12 2000-08-07 Therapeutic compositions and methods of use thereof
PCT/US2000/031086 WO2001034165A1 (en) 1999-11-12 2000-11-13 Therapeutic compositions and methods of use thereof

Publications (1)

Publication Number Publication Date
BR0015478A true BR0015478A (pt) 2004-04-27

Family

ID=27032197

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0015478-4A BR0015478A (pt) 1999-11-12 2000-11-13 Métodos de diminuição do volume de uma célula, de tratamento de pessoa e de inflamação, de dessensibilização de dente e de redução de dor em úlceras, composição terapêutica, cimento dentário, goma de mascar ou bala e composições dentárias e de branquamento dentário

Country Status (8)

Country Link
US (2) US6524623B1 (pt)
EP (1) EP1227821A4 (pt)
JP (1) JP2003521482A (pt)
AU (1) AU777821B2 (pt)
BR (1) BR0015478A (pt)
CA (1) CA2391278A1 (pt)
MX (1) MXPA02004770A (pt)
WO (1) WO2001034165A1 (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050113460A1 (en) * 1999-04-30 2005-05-26 The Regents Of The University Of Michigan Compositions and methods relating to novel compounds and targets thereof
US20040176358A1 (en) * 1999-04-30 2004-09-09 The Regents Of The University Of Michigan Compositions and methods relating to novel compounds and targets thereof
US7572788B2 (en) * 1999-04-30 2009-08-11 The Regents Of The University Of Michigan Compositions and methods relating to novel compounds and targets thereof
US20060025388A1 (en) * 1999-04-30 2006-02-02 Glick Gary D Compositions and methods relating to novel compounds and targets thereof
ES2214273T3 (es) * 1999-04-30 2004-09-16 The Regents Of The University Of Michigan Utilizacion de benzodiazepinas para el tratamiento de enfermedades autoinmunes inducidas por apoptosis.
US6524623B1 (en) * 1999-11-12 2003-02-25 Milton Hodosh Therapeutic compositions and methods of use thereof
EA011309B1 (ru) 2000-06-13 2009-02-27 Вайет Составы для ослабления боли, содержащие целекоксиб
US8900607B1 (en) * 2002-09-25 2014-12-02 Chemsil Silicones, Inc. Clear, greaseless skin-care compositions
GB0315269D0 (en) * 2003-07-01 2003-08-06 Maleno Idalecio B F Mouth and/or throat wash
US20050272723A1 (en) * 2004-04-27 2005-12-08 The Regents Of The University Of Michigan Methods and compositions for treating diseases and conditions associated with mitochondrial function
US8652445B2 (en) * 2004-07-02 2014-02-18 Discus Dental, Llc Dental compositions with sensitivity relief
CA2573720A1 (en) 2004-07-14 2006-02-23 University Of Utah Research Foundation Netrin-related compositions and uses
US20060052369A1 (en) * 2004-09-07 2006-03-09 The Regents Of The University Of Michigan Compositions and methods relating to novel compounds and targets thereof
US20060147504A1 (en) * 2004-12-30 2006-07-06 Bobby Corry Feminine anti-itch cloth
JP2008528448A (ja) 2005-01-03 2008-07-31 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 新規化合物に関連する組成物および方法、ならびにその標的
CA2595615C (en) * 2005-01-27 2014-05-20 C.B. Fleet Company Incorporated Feminine anti-itch gel
JP2008545757A (ja) 2005-06-01 2008-12-18 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 溶媒和されていないベンゾジアゼピン組成物および方法
JP5241501B2 (ja) 2005-11-01 2013-07-17 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 治療特性を有する新規の１，４−ベンゾジアゼピン−２，５−ジオン
US7759338B2 (en) * 2006-04-27 2010-07-20 The Regents Of The University Of Michigan Soluble 1,4 benzodiazepine compounds and stable salts thereof
EP2037741B1 (en) 2006-06-09 2013-11-27 The Regents Of The University Of Michigan Benzodiazepine derivatives for use in the treatment of immune, inflammatory and proliferative disorders
EP2139331B1 (en) 2007-03-09 2013-02-20 The Regents of the University of Michigan Compositions and methods relating to novel compounds and targets thereof
CN101855203B (zh) 2007-09-14 2014-03-19 密执安州立大学董事会 F1f0-atp合成酶抑制剂以及相关的方法
CA2703005A1 (en) 2007-11-06 2009-05-14 The Regents Of The University Of Michigan Benzodiazepinone compounds useful in the treatment of skin conditions
WO2010030891A2 (en) 2008-09-11 2010-03-18 The Regents Of The University Of Michigan Aryl guanidine f1f0-atpase inhibitors and related methods
WO2010121164A2 (en) 2009-04-17 2010-10-21 The Regents Of The University Of Michigan 1,4-benzodiazepinone compounds and their use in treating cancer
US8673897B2 (en) 2009-09-18 2014-03-18 The Regents Of The University Of Michigan Benzodiazepinone compounds and methods of treatment using same
US8496917B2 (en) * 2009-11-13 2013-07-30 Sytheon Ltd Compositions and methods for improving skin appearance
JP5856064B2 (ja) 2009-11-17 2016-02-09 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 治療特性を有する１，４−ベンゾジアゼピン−２，５−ジオンおよび関連化合物
CA2915237C (en) 2009-11-17 2017-10-10 The Regents Of The University Of Michigan 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
BR112016014611A8 (pt) 2013-12-24 2023-05-09 Univ Virginia Commonwealth Usos de sulfatos de colesterol oxigenados (ocs)
US20150297508A1 (en) * 2014-04-21 2015-10-22 William Andriette Topical Formulation to Enhance Genital Sensation and Function
DK3273951T3 (da) 2015-03-27 2020-11-02 Symbionyx Pharmaceuticals Inc Sammensætninger og fremgangsmåder til behandling af psoriasis
US10597402B2 (en) 2015-03-27 2020-03-24 Sytheon Limited Compositions and methods for restoring epidermal integrity and function and treating dermatological diseases
WO2023091047A1 (ru) * 2021-11-22 2023-05-25 "Скайлаб At" Новое применение сегнетовой соли

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4060600A (en) 1972-10-26 1977-11-29 National Patent Development Corporation Treating teeth
US3863006A (en) 1973-01-29 1975-01-28 Milton Hodosh Method for desensitizing teeth
US4191750A (en) 1976-03-08 1980-03-04 Milton Hodosh Method for treating canker sores
US4082881A (en) * 1976-12-23 1978-04-04 E. R. Squibb & Sons, Inc. Topical and other type pharmaceutical formulations containing isosorbide carrier
US4228162A (en) * 1979-07-09 1980-10-14 Research Corporation Dimethyl isosorbide in liquid formulation of aspirin
US4343608A (en) 1980-03-03 1982-08-10 Milton Hodosh Compound and method for preserving dental pulp
US4407675A (en) 1980-03-03 1983-10-04 Milton Hodosh Composition for preserving dental pulp
US4383986A (en) * 1981-08-17 1983-05-17 Ortho Pharmaceutical Corporation Hemorrhoidal compositions
US4400373A (en) 1981-12-15 1983-08-23 Milton Hodosh Method for treating gingival and periodontal tissues
DE3314895A1 (de) 1983-04-25 1984-10-25 Blendax-Werke R. Schneider Gmbh & Co, 6500 Mainz Zahn- und mundpflegemittel
FI75734C (fi) 1984-12-18 1988-08-08 Lilius Kaj Rainer Munskoeljningsloesning.
US4627980A (en) 1984-12-21 1986-12-09 Ici Americas Inc. Hard candy dentifrice formulation and method of treating teeth, mouth and throat therewith to reduce irritation and plaque accumulation
US4627975A (en) 1984-12-21 1986-12-09 Ici Americas Inc. Dental floss dentifrice formulation and method of treating teeth, mouth and throat therewith to reduce plaque accumulation and irritation
US4627979A (en) 1984-12-21 1986-12-09 Ici Americas Inc. Toothpaste dentifrice formulation and method of treating teeth, mouth and throat therewith to reduce plaque accumulation and irritation
US4627976A (en) 1984-12-21 1986-12-09 Ici Americas Inc. Dentifrice formulation and method of treating teeth, mouth and throat therewith to reduce plaque accumulation and irritation
US4627978A (en) 1984-12-21 1986-12-09 Ici Americas Inc. Tooth drop dentifrice formulation and method of treating teeth, mouth and throat therewith to reduce plaque accumulation and irritation
US4610871A (en) 1984-12-21 1986-09-09 Ici Americas Inc. Dentifrice formulation and method of treating teeth, mouth and throat therewith to reduce plaque accumulation and irritation
US4610872A (en) 1984-12-21 1986-09-09 Ici Americas Inc. Dentifrice formulation and method of treating teeth, mouth and throat therewith to reduce plaque accumulation and irritation
US4632937A (en) 1984-12-21 1986-12-30 Ici Americas Dentifrice formulation and method of treating teeth, mouth and throat therewith to reduce plaque accumulation and irritation
US4585649A (en) 1984-12-21 1986-04-29 Ici Americas Inc. Dentifrice formulation and method of treating teeth, mouth and throat therewith to reduce plaque accumulation and irritation
US4627974A (en) 1984-12-21 1986-12-09 Ici Americas Inc. Dentifrice formulation and method of treating teeth, mouth and throat therewith to reduce plaque accumulation and irritation
JPH07100685B2 (ja) 1985-08-02 1995-11-01 レオ・ファ−マシュ−ティカル・プロダクツ・リミテッド・エイ／エス（レ−ベンス・ケミスケ・ファブリック・プロデュクチオンスアクチ−セルスカブ） 新規ビタミンｄ類似体
US4711904A (en) * 1986-08-04 1987-12-08 Luzzi Louis A Method of treating skin disorders
JPS6445308A (en) 1987-08-12 1989-02-17 Yasuhiro Asai Dental cleaning material
US4770871A (en) 1987-11-06 1988-09-13 Ici Americas Inc. Process for the preparation of dianhydrosorbitol ethers
US4961923A (en) 1988-02-19 1990-10-09 Dentsply Management Corp. Irrigants for use in scaling and/or lavage apparatus
US5139768A (en) 1989-01-31 1992-08-18 Yissum Research Development Company Of The Hebrew University Of Jerusalem Dental composition for hypersensitive teeth
US5015466A (en) * 1990-06-26 1991-05-14 The Procter & Gamble Company Anticalculus compositions using tartrate-succinates
US5147632A (en) 1990-10-31 1992-09-15 Warner-Lambert Company Anti-plaque compositions comprising a combination of morpholinoamino alcohol and chelating agent
GB9025711D0 (en) * 1990-11-27 1991-01-09 Beecham Group Plc Topical composition
US5153006A (en) 1991-08-12 1992-10-06 Milton Hodosh Method of treating post-restoration dental pain
US5374417A (en) 1991-10-17 1994-12-20 Colgate Palmolive Company Desensitizing dentifrice
IL112649A (en) * 1994-02-22 1999-12-22 Curtis Helene Ind Inc Topically effective compositions for application to the skin or hair
US5522726A (en) 1994-10-27 1996-06-04 Hodosh; Milton Method for anesthetizing teeth
US5989535A (en) * 1997-08-15 1999-11-23 Soma Technologies Polymeric bioadhesive emulsions and suspensions and methods of treatment
US5875798A (en) * 1997-09-23 1999-03-02 Advanced Medical Instruments, Inc. Therapeutic toothpick for treating oral and systemic diseases
FR2774595A1 (fr) * 1998-02-06 1999-08-13 Rech D Innovation Et De Dev Ce Emulsion pour l'administration transdermique de steroides
US6032388A (en) * 1998-05-01 2000-03-07 Puma Ag Rudolf Dassler Sport Thin, flexible shoe outsole with injected-through tread elements, a method of producing such an outsole and a shoe provided with such an outsole
PT1150661E (pt) * 1999-02-05 2004-02-27 Cipla Ltd Produto para pulverizacao para aplicacao topica
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6099868A (en) * 1999-11-12 2000-08-08 Hodosh; Milton Method of using potassium nitrate for pain reduction
US6524623B1 (en) * 1999-11-12 2003-02-25 Milton Hodosh Therapeutic compositions and methods of use thereof

Also Published As

Publication number Publication date
JP2003521482A (ja) 2003-07-15
MXPA02004770A (es) 2003-10-14
US20030003163A1 (en) 2003-01-02
EP1227821A4 (en) 2004-09-22
EP1227821A1 (en) 2002-08-07
CA2391278A1 (en) 2001-05-17
AU777821B2 (en) 2004-11-04
AU1657201A (en) 2001-06-06
US7115252B2 (en) 2006-10-03
US6524623B1 (en) 2003-02-25
WO2001034165A1 (en) 2001-05-17

Similar Documents

Publication Publication Date Title
BR0015478A (pt) Métodos de diminuição do volume de uma célula, de tratamento de pessoa e de inflamação, de dessensibilização de dente e de redução de dor em úlceras, composição terapêutica, cimento dentário, goma de mascar ou bala e composições dentárias e de branquamento dentário
BRPI9908182C1 (pt) composições de proteína de matriz para cura de feridas
ES2151968T3 (es) Composiciones hemorroidales y metodo de utilizacion.
DE69613840D1 (de) Orale dosierungsform und verfahren zur behandlung von schmerzzuständen in dermundhöhle
MY144292A (en) Method of reducing oral tissue inflammation using magnolia extract
IS4083A (is) Samsetning lyfjaefna, aðferð til framleiðslu hennar, og notkunar sem lyfja
TR200100931T2 (tr) Yeni sürekli salınımlı oral formülasyonlar
ATE264102T1 (de) Nicotin enthaltende pharmazeutische zusammensetzungen mit schneller transmukosaler absorption
BRPI0519178A2 (pt) composiÇço de cuidado oral, e, mÉtodo de prevenir ou tratar cÁrie dental em um indivÍduo humano ou animal
GB0015682D0 (en) Sprayable wound care composition
CA2424566A1 (en) Dental care compositions
WO2002026191A3 (en) Methods, compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue
DE60206476D1 (de) Remineralisierendes zahnpflegemittel
ATE199641T1 (de) Terpenderivate (sarcodictyine) als antikrebsmittel
BR9912533A (pt) Composição farmacêutica tendo sabor melhorado
TR199901385T2 (xx) Piperidin t�revleri.
DK0927031T3 (da) Farmaceutisk sammensætning indeholdende nimesulid til oral admnistration
ATE271862T1 (de) Nsaid enthaltendes wasserfreies gel zur topischen anwendung in der mundhöhle
AR017170A1 (es) Composicion oftalmologica
Li et al. Control Plaque And Gingivitis Through Different Kinds Of Toothbrushes
RU92011668A (ru) Лечебно-профилактическая зубная паста "осинка"
Kakran Pedodontics: ORIGINAL REVIEW Ozone Therapy in Dental Practice-A concise review.
UA40496A (uk) Спосіб лікування генералізованого пародонтиту з відновленням нормобіозу пародонтальних тканин
KR970032815A (ko) 구강내 염증 치료용 조성물
KR970025618A (ko) 한방약 수소를 주재로 한 화상치료용 한방고약의 제조방법

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 13, 24 E 25 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.